FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formulae
and ,
which can be used to inhibit lipid kinase, including PI3K, and treat lipid kinase-mediated disorders. Values of radicals are given in claim 1.
EFFECT: improved properties of the compound.
11 cl, 2 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
PHOSPHOINOSITIDE-3-KINASE INHIBITORS AND METHODS FOR USE THEREOF | 2007 |
|
RU2468027C2 |
PHOSPHOINOSITIDE-3-KINASE INHIBITORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID INHIBITORS | 2007 |
|
RU2437888C2 |
PHARMACEUTICAL COMPOUNDS | 2005 |
|
RU2422449C2 |
PHARMACEUTICAL COMPOUNDS | 2005 |
|
RU2422448C2 |
TRIAZINE, PYRIMIDINE AND PYRIDINE ANALOGUES AND USE THEREOF AS THERAPEUTIC AGENTS AND DIAGNOSTIC SAMPLES | 2009 |
|
RU2537945C2 |
PHOSPHOINOSITIDE3-KINASE INHIBITING COMPOUNDS AND METHODS FOR USE THEREOF | 2007 |
|
RU2470936C2 |
THIENO[3,2-d]PYRIMIDINE DERIVATIVE AS PHOSPHATIDYL INOSITOL-3-KINASE (PI3K) INHIBITOR | 2007 |
|
RU2439074C2 |
PI3-KINASE INHIBITORS AND USE THEREOF | 2010 |
|
RU2595718C2 |
PYRIMIDINE DERIVATIVES AS ALK-5 INHIBITORS | 2007 |
|
RU2485115C2 |
AZAINDOL DERIVATIVES AS FACTOR Xa INHIBITORS | 2004 |
|
RU2330853C2 |
Authors
Dates
2012-02-27—Published
2007-04-24—Filed